Veronica Lopez Gousset, MPH has over 10 years of experience driving multi-stakeholder initiatives toward patient-centered healthcare change. She works with the patient community to better voice their needs and challenges, with health technology assessment bodies as the gateway to services and therapies in many countries, and with the pharmaceutical industry to inform research and commercialization plans based on patient priorities. Since 2020, she has been working to support the characterization of the impact of patient involvement in HTA. She has presented, trained, and published on this topic. She is now kicking off an effort under HTAi’s Patient and Citizen Involvement Interest Group (PCIG) to operationalize the published framework across HTA bodies and contexts. She is a Steering Committee member of HTAi’s Rare Disease Interest Group and co-leads the group’s project on knowledge mobilization. Veronica is currently pursuing a Doctorate in Public Health (DrPH) from the Harvard T.H. Chan School of Public Health, and she has a Master's degree in Public Health (MPH) with a concentration in health policy from the Columbia Mailman School of Public Health in New York.
This panel will explore the practical implications that industry and patient organizations need to consider when engaging given the evolving landscape of HTA in Europe